216 related articles for article (PubMed ID: 9283682)
1. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP
Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
[TBL] [Abstract][Full Text] [Related]
2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
3. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery.
Randall MD; Kendall DA
Eur J Pharmacol; 1998 Apr; 346(1):51-3. PubMed ID: 9617751
[TBL] [Abstract][Full Text] [Related]
4. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of anandamide in rat hepatic artery.
Zygmunt PM; Högestätt ED; Waldeck K; Edwards G; Kirkup AJ; Weston AH
Br J Pharmacol; 1997 Dec; 122(8):1679-86. PubMed ID: 9422814
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
7. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
Fleming I; Schermer B; Popp R; Busse R
Br J Pharmacol; 1999 Feb; 126(4):949-60. PubMed ID: 10193775
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
Randall MD; McCulloch AI; Kendall DA
Eur J Pharmacol; 1997 Aug; 333(2-3):191-7. PubMed ID: 9314035
[TBL] [Abstract][Full Text] [Related]
10. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
12. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
Vanheel B; Van de Voorde J
J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613
[TBL] [Abstract][Full Text] [Related]
13. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
15. An endogenous cannabinoid as an endothelium-derived vasorelaxant.
Randall MD; Alexander SP; Bennett T; Boyd EA; Fry JR; Gardiner SM; Kemp PA; McCulloch AI; Kendall DA
Biochem Biophys Res Commun; 1996 Dec; 229(1):114-20. PubMed ID: 8954092
[TBL] [Abstract][Full Text] [Related]
16. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
Randall MD; Kendall DA
Eur J Pharmacol; 1997 Sep; 335(2-3):205-9. PubMed ID: 9369375
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels.
Dong H; Jiang Y; Cole WC; Triggle CR
Br J Pharmacol; 2000 Aug; 130(8):1983-91. PubMed ID: 10952691
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries.
Wheal AJ; Alexander SP; Randall MD
Eur J Pharmacol; 2012 Jan; 674(2-3):384-90. PubMed ID: 22154756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]